New IT Sector Report Evaluates 300+ Vendors Across 40 Categories, Revealing 2025's Top-Rated Solutions in Women's Health ...

The global immunotoxins market was valued at USD 159.9 million in 2024 and is projected to expand at a compound annual growth ...

New location offers extended hours and same-day urgent care for pets-seven days a week. SUMMERVILLE, SOUTH CAROLINA / ACCESS Newswire / May 7, 2025 / AcutePet Urgent Care is proud to announce the ...

Dr. Kirk Lozada details how tip-plasty can benefit patients with isolated nasal tip concerns and explores criteria for safe, ...

Healthcare professionals increasingly prioritize workplace support systems, with 3 in 4 considering mental health support a key factor when evaluating job opportunities.Skills gaps are widening in the ...

LONDON, May 07, 2025 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, today announced it will present ...

Will champion community blood centers’ role in advancing cell and gene, blood therapies that enhance patient care Washington, DC and Wyoming, MAY 7, 2025 – America’s Blood Centers (ABC), the national ...

The EAESS, founded by Dr. Ghassan Elgeadi, will be officially presented in Madrid as a meeting point for the European medical community of this specialty.Madrid - Spine surgery in Europe marks a new ...

Ludwig Enterprises, Inc. (OTC:LUDG), previews its first in a pipeline of non-invasive cancer screening tests powered by mRNA biomarker analysis. MIAMI, FL / ACCESS Newswire / May 7, 2025 / Ludwig ...

Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis patients.All patients experienced stabilization of Expanded Disability ...

Celerion, a global leader in early clinical research and bioanalytical services, announced the launch of the latest version of Labnotes, its cutting-edge bioanalytical electronic laboratory notebook ...

Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet ...